Saturated Fatty Acid Has Reduced Atherosclerosis in Mice
Researchers identified a specific gut metabolite that may help lower plaque buildup in cardiovascular disease.
Updated on Oct. 7, 2026 in Heart Disease
Live Poll
Does new research on gut bacteria make you more optimistic about future medical treatments?
Scientists have discovered that pentadecanoic acid, a metabolite produced by certain gut bacteria, reduced atherosclerotic plaque by 50% in mouse models. This preliminary finding marks a new step in understanding how the microbiome influences heart health.
Why it matters
Identifying these metabolites offers potential new avenues for managing dyslipidemia, a major risk factor for heart disease. This research highlights how specific bacterial strains in the gut may actively communicate with the liver to regulate cholesterol levels.
In a preclinical study analyzing 100 gut bacterial strains, researchers found that pentadecanoic acid, a key metabolite of Bacteroides, significantly reduced plaque buildup. These results are preliminary and limited to findings in mouse models.
The players
Bacteroides uniformis
A gut bacterial strain that was shown to improve cholesterol regulation in animal models.
The details
Pentadecanoic acid functions by inhibiting HMG-CoA reductase, an enzyme critical to cholesterol production in the liver. Furthermore, administration of Bacteroides uniformis was found to upregulate hepatic low-density lipoprotein receptor expression, which promotes the clearance of LDL cholesterol from the blood. By suppressing hepatic cholesterol biosynthesis and enhancing plasma cholesterol removal, this fatty acid helps mitigate the progression of atherosclerosis.
Timeline
October 7, 2026: The study results were published.
Health Landscape
This study contributes to the growing body of research investigating the human microbiome-cholesterol axis. It provides a mechanistic link between specific gut metabolites and the regulation of hepatic cholesterol, moving beyond descriptive associations to functional intervention.
While this study helps explain why gut health matters for cardiovascular risk, these results are strictly preliminary and limited to mouse models. It is not currently clear if dietary or supplemental intake of pentadecanoic acid provides similar benefits, so avoid changing your regimen.
The takeaway
This research provides a new understanding of how gut bacteria can influence cholesterol management by altering hepatic function. Patients interested in how emerging microbiome science may one day influence their heart health should continue to consult their primary care physician.
Further reading
For more on the latest research in managing cardiovascular risk, visit our Heart Disease section.
More information
Read the full scientific research study published in Nature.
Live Poll
Does new research on gut bacteria make you more optimistic about future medical treatments?
